These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 35782247)

  • 1. A simplified scoring protocol to improve diagnostic accuracy with the breast imaging reporting and data system in breast magnetic resonance imaging.
    Zhong Y; Li M; Zhu J; Zhang B; Liu M; Wang Z; Wang J; Zheng Y; Cheng L; Li X
    Quant Imaging Med Surg; 2022 Jul; 12(7):3860-3872. PubMed ID: 35782247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of MRI for architectural distortion categorized as BI-RADS category 3-4 by mammography.
    Mei H; Xu J; Yao G; Wang Y
    Gland Surg; 2020 Aug; 9(4):1008-1018. PubMed ID: 32953609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
    Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
    Li X; Wang H; Gao J; Jiang L; Chen M
    Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
    Liu D; Ba Z; Ni X; Wang L; Yu D; Ma X
    Med Sci Monit; 2018 Apr; 24():2180-2188. PubMed ID: 29644993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
    Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
    Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis.
    Cui Q; Sun L; Zhang Y; Zhao Z; Li S; Liu Y; Ge H; Qin D; Zhao Y
    Ann Transl Med; 2021 Nov; 9(22):1677. PubMed ID: 34988186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple scoring system for breast MRI interpretation: does it compensate for reader experience?
    Marino MA; Clauser P; Woitek R; Wengert GJ; Kapetas P; Bernathova M; Pinker-Domenig K; Helbich TH; Preidler K; Baltzer PA
    Eur Radiol; 2016 Aug; 26(8):2529-37. PubMed ID: 26511631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
    Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
    Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Kaiser score on contrast-enhanced mammography in the differential diagnosis of breast lesions: comparison with breast magnetic resonance imaging.
    Rong X; Kang Y; Li Y; Xue J; Li Z; Yang G
    Quant Imaging Med Surg; 2024 Aug; 14(8):5541-5554. PubMed ID: 39144044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications.
    Youk JH; Son EJ; Kim JA; Moon HJ; Kim MJ; Choi CH; Kim EK
    Ann Surg Oncol; 2012 May; 19(5):1491-8. PubMed ID: 22173328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of B-mode ultrasound Breast Imaging Reporting and Data System category 3-4a lesions in conjunction with shear-wave elastography using conservative and aggressive approaches.
    Zhi W; Miao A; You C; Zhou J; Zhang H; Zhu X; Wang Y; Chang C
    Quant Imaging Med Surg; 2022 Jul; 12(7):3833-3843. PubMed ID: 35782244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of multimodal imaging in the diagnosis of breast sclerosing adenosis associated with malignant lesions.
    Chen H; Bao L; Yu L; Sun H; Tan Y; Wei P; Zheng Z
    J Clin Ultrasound; 2023 Mar; 51(3):485-493. PubMed ID: 36250329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiparametric classification system for lesions detected by breast magnetic resonance imaging.
    Istomin A; Masarwah A; Okuma H; Sutela A; Vanninen R; Sudah M
    Eur J Radiol; 2020 Nov; 132():109322. PubMed ID: 33045483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
    Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-aided classification of BI-RADS category 3 breast lesions.
    Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
    Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.